Home Cassandra Williamson-Hopp

2023 BPS coverage: Diabetes, asthma, ADHD account for high drug claims in 2022

Three main drug categories — diabetes, asthma and stimulants for attention deficit hyperactivity disorder — accounted for rising drug claims in 2022, according to Lavina Viegas, Telus Health’s director of client account management, speaking during Benefits Canada‘s 2023 Benefits & Pension Summit in June. Referring to Telus Health’s 2023 drug plan trends report, she said […]

  • July 5, 2023 June 26, 2023
  • 07:56

Employers should rethink approach to helping employees with obesity

Employers that don’t cover obesity drugs should ask themselves why, said Noel McKay, principal consultant at Cowan Insurance Group, during Benefits Canada’s Face to Face Drug Plan Management Forum on Dec. 9, 2020. “Is the risk of driving up benefits costs the reason? If so, I don’t think you have to fear it. Maybe two […]

  • January 15, 2021 April 14, 2021
  • 08:58